New cancer drug JAB-8263 tested in early human trial
NCT ID NCT04587479
First seen Jan 17, 2026 · Last updated May 06, 2026 · Updated 16 times
Summary
This early-stage study tested a new drug called JAB-8263 in 41 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find a safe dose and check for side effects. The study did not aim to cure the cancer, but to gather information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS, ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Florida Cancer Center, Lake Mary
Lake City, Florida, 32025, United States
-
SCRI HeatlthONE
Denver, Colorado, 80218, United States
-
Tennessee Oncology Nashville
Nashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.